Literature DB >> 26708937

Cancer immune contexture and immunotherapy.

Etienne Becht1, Nicolas A Giraldo1, Marie-Caroline Dieu-Nosjean1, Catherine Sautès-Fridman1, Wolf Herman Fridman2.   

Abstract

The immune contexture that characterizes the density, the location, the organization and the functional orientation of tumor-infiltrating immune cells in cancers has a clinical impact on patient's outcome. It is, in great part, shaped by the malignant cells, as in a given cancer type, tumors presenting different oncogenic processes have different immune contextures. Moreover, the immune contexture in metastatic sites reflects that of the corresponding primary tumors. Finally, the components forming the immune contexture represent targets and markers of efficient anti-cancer immunotherapies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26708937     DOI: 10.1016/j.coi.2015.11.009

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  54 in total

1.  Molecular Pathogenesis and Classification of Colorectal Carcinoma.

Authors:  Anup Kasi; Shivani Handa; Sajjad Bhatti; Shahid Umar; Ajay Bansal; Weijing Sun
Journal:  Curr Colorectal Cancer Rep       Date:  2020-08-15

Review 2.  The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Authors:  Sara Hadjigol; Bansari A Shah; Neil M O'Brien-Simpson
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 3.  Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.

Authors:  Amos Kirilovsky; Florence Marliot; Carine El Sissy; Nacilla Haicheur; Jérôme Galon; Franck Pagès
Journal:  Int Immunol       Date:  2016-04-27       Impact factor: 4.823

4.  Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes.

Authors:  Dmitry Aleksandrovich Zinovkin; Md Zahidul Islam Pranjol; Il'ya Andreevich Bilsky; Valeriya Alexandrovna Zmushko
Journal:  Cancer Microenviron       Date:  2018-07-14

5.  MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis.

Authors:  Cheng Yuan; Liyang Xiang; Rui Bai; Kuo Cao; Yanping Gao; Xueping Jiang; Nannan Zhang; Yan Gong; Conghua Xie
Journal:  Ann Transl Med       Date:  2019-06

Review 6.  Metabolism of immune cells in cancer.

Authors:  Robert D Leone; Jonathan D Powell
Journal:  Nat Rev Cancer       Date:  2020-07-06       Impact factor: 60.716

7.  Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.

Authors:  Anjan K Pradhan; Santanu Maji; Praveen Bhoopathi; Sarmistha Talukdar; Padmanabhan Mannangatti; Chunqing Guo; Xiang-Yang Wang; Lorraine Colon Cartagena; Michael Idowu; Joseph W Landry; Devanand Sarkar; Luni Emdad; Webster K Cavenee; Swadesh K Das; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

8.  KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer.

Authors:  Neeraj Lal; Brian S White; Ghaleb Goussous; Oliver Pickles; Mike J Mason; Andrew D Beggs; Philippe Taniere; Benjamin E Willcox; Justin Guinney; Gary W Middleton
Journal:  Clin Cancer Res       Date:  2017-10-23       Impact factor: 12.531

9.  Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy.

Authors:  Isaure Vanmeerbeek; Daniel M Borras; Jenny Sprooten; Oliver Bechter; Sabine Tejpar; Abhishek D Garg
Journal:  Genes Immun       Date:  2021-06-02       Impact factor: 2.676

10.  GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma.

Authors:  Yilin Yu; Zhiping Wang; Qunhao Zheng; Jiancheng Li
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.